Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013;3(4):461-91.
doi: 10.3233/JPD-130230.

The role of oxidative stress in Parkinson's disease

Affiliations
Review

The role of oxidative stress in Parkinson's disease

Vera Dias et al. J Parkinsons Dis. 2013.

Abstract

Oxidative stress plays an important role in the degeneration of dopaminergic neurons in Parkinson's disease (PD). Disruptions in the physiologic maintenance of the redox potential in neurons interfere with several biological processes, ultimately leading to cell death. Evidence has been developed for oxidative and nitrative damage to key cellular components in the PD substantia nigra. A number of sources and mechanisms for the generation of reactive oxygen species (ROS) are recognized including the metabolism of dopamine itself, mitochondrial dysfunction, iron, neuroinflammatory cells, calcium, and aging. PD causing gene products including DJ-1, PINK1, parkin, alpha-synuclein and LRRK2 also impact in complex ways mitochondrial function leading to exacerbation of ROS generation and susceptibility to oxidative stress. Additionally, cellular homeostatic processes including the ubiquitin-proteasome system and mitophagy are impacted by oxidative stress. It is apparent that the interplay between these various mechanisms contributes to neurodegeneration in PD as a feed forward scenario where primary insults lead to oxidative stress, which damages key cellular pathogenetic proteins that in turn cause more ROS production. Animal models of PD have yielded some insights into the molecular pathways of neuronal degeneration and highlighted previously unknown mechanisms by which oxidative stress contributes to PD. However, therapeutic attempts to target the general state of oxidative stress in clinical trials have failed to demonstrate an impact on disease progression. Recent knowledge gained about the specific mechanisms related to PD gene products that modulate ROS production and the response of neurons to stress may provide targeted new approaches towards neuroprotection.

Keywords: Neurodegeneration; dopamine; mitochondria; neuroinflammation; neuroprotection; reactive oxygen species.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

None.

Figures

Fig. 1
Fig. 1
Mechanisms leading to oxidative stress in PD and the role of PD-related gene products in this process. DA = dopamine; ROS = reactive oxygen species; UPS = ubiquitin-proteasome system; GSH = glutathione.

References

    1. Fahn S, Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. Neuro Rx. 2004;1:139–154. - PMC - PubMed
    1. Sulzer D, Surmeier DJ. Neuronal vulnerability, pathogenesis, and Parkinson’s disease. Mov Disord. 2013;28:41–50. - PMC - PubMed
    1. Schapira AH, Jenner P. Etiology and pathogenesis of Parkinson’s disease. Mov Disord. 2011;26:1049–1055. - PubMed
    1. Zhu J, Chu CT. Mitochondrial dysfunction in Parkinson’s disease. J Alzheimers Dis. 2010;20(Suppl 2):S325–S334. - PubMed
    1. Parker WD, Parks JK, Swerdlow RH. Complex I deficiency in Parkinson’s disease frontal cortex. Brain Res. 2008;16:215–218. - PMC - PubMed

Publication types

MeSH terms